Biomedical Excellence for Safer Transfusion Colaborative
Revenue
$355k
year to 31 December 2024
Expenses
$449k
year to 31 December 2024
Total assets
$751k
$0 liabilities
Net assets
$751k
assets less liabilities
Directors and trustees
11
4.8y av
Staff
0
employees, year to 31 December 2024
Left since last filing
0
no seats appear to have opened
Voting members
10
reported in Part VI
Biomedical Excellence for Safer Transfusion Colaborative's network
11 peoplei11 people on this map.The large node is the subject of this page. Solid lines are what the register itself records (11). Form 990 filings give names without a person identifier; SEC insider filings carry a CIK.The board
11 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 10 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| David McKenna MD (also filed as David McKenna) | Director | 2020 | 6 yrs |
| David Stroncek MD (also filed as David Stroncek) | Director | 2020 | 6 yrs |
| Denese Marks PhD | Director | 2023 | 3 yrs |
| Eileen Selogie MLS Mtascpsbb | Executive Director | 2023 | 3 yrs |
| Jason Acker PhD MBA | Director | 2023 | 3 yrs |
| Marc Germain MD (also filed as Marc Germain) | Director | 2021 | 5 yrs |
| Meghan Delaney DO MPH (also filed as Meghan Delaney) | Director | 2022 | 4 yrs |
| Ralph Vassallo MD (also filed as Ralph Vassallo) | Director | 2020 | 6 yrs |
| Rebecca Cardigan PhD | President | 2023 | 3 yrs |
| Simon Stanworth MA Fcrp PhD FRC | Director | 2023 | 3 yrs |
| Zbigniew Szczepiorkowski MD PhD (also filed as Zbigniew Szczepiorkowski, Zbigniew Szczepiorkowski MD) | Treasurer Interim President | 2020 | 6 yrs |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Eileen Selogie MLS MTASCPSBB | Executive Director | 60 | $150k | ||
| Rebecca Cardigan PhD | President | 20 | $0 | ||
| Zbigniew Szczepiorkowski MD PhD | Treasurer Interim President | 20 | $0 | ||
| Michael F Murphy MD | Consulting Past President | 5 | $0 | ||
| David Stroncek MD | Director | 5 | $0 | ||
| David McKenna MD | Director | 5 | $0 | ||
| Ralph Vassallo MD | Director | 5 | $0 | ||
| Marc Germain MD | Director | 5 | $0 | ||
| Denese Marks PhD | Director | 5 | $0 | ||
| Jason Acker PhD MBA | Director | 5 | $0 | ||
| Meghan Delaney DO MPH | Director | 5 | $0 | ||
| Simon Stanworth MA FCRP PhD FRC | Director | 5 | $0 |
About
- Legal name
- Biomedical Excellence for Safer Transfusion Colaborative
- EIN
- 050602179
- Address
- 4224 Mildred Ave, Los Angeles, CA, 90066-6115
- State
- California
- Mission
- Were a unique international collaborative of blood providers industry and academic experts. Through working together to undertake studies publishing guidance and recommending procedures we aim to improve the safety quality and effectiveness of transfusion medicine and cellular therapies worldwide. We use our pooled resources to take on projects and challenges that would be unfeasible to... (as filed on the Form 990)
- Activity (NTEE)
- U50 Science and technology research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Science & Technology
- Size band
- 5 (IRS master file code)
- Formed
- 2004
- Principal officer
- Zbigniew Szczepiorkowski (as named on the Form 990)
- IRS ruling date
- 1 November 2005
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 5, latest 2024
- IRS Publication 78
- FORGN
Most connected
Longest observed on the filings
≥6years on the filingsDavid McKenna MD
≥6years on the filingsDavid Stroncek MD
≥6years on the filingsRalph Vassallo MD
≥6years on the filingsZbigniew Szczepiorkowski MD PhD
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $751k
- Total liabilities
- $0
- Net assets or fund balances
- $751k
- Contributions and grants received
- $340k
- Program service revenue
- $0
- Employees
- 0
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $355k | $449k | Deficit $94k |
As filed on the IRS Form 990. US dollars.